About the Authors

Drosophila Models of Human Disease was founded in 2012 by Stephanie E. Mohr, PhD, who has more than twenty years of experience in Drosophila genetics and related research.

First in Fly webpage
Stephanie is a Lecturer on Genetics and the Director of the DRSC/TRiP Functional Genomics Resources in the Department of Genetics at Harvard Medical School. Grant support for the DRSC and related activities includes NIH NIGMS R01 GM067761 and other funding from the National Institutes of Health (NCRR/ORIP, NCI, and NIGMS).

Stephanie is also the author of First in Fly: Drosophila Research and Biological Discovery (March 2018, Harvard University Press). More information about First in Fly, which is aimed at a non-expert audience, is available at the HUP web page for the book.

Follow Stephanie on Twitter @smohrfly

Learn more about Stephanie, including upcoming speaking engagements, at Harvard Scholar.

Additional Authors

We are pleased to have Annette Parks, PhD, from the Bloomington Drosophila Stock Center (BDSC) as an additional contributing author. Annette plans to focus on fly stock resources related to human diseases, including deposited fly disease model fly stocks newly deposited to BDSC.

You can contribute! Experts interested to become one-time or frequently contributing co-authors of the blog should contact Stephanie. Her contact information is available online from the DRSC/TRiP Functional Genomics, Harvard Medical School or FlyBase People.

1 comment:

  1. I have a high school student interested in doing research on type 1 diabetes using Drosophila, specifically the effect of vitamin D supplementation. Most of the papers she has looked at use IPC ablation to produce TD1 models in flies rather than a particular mutant strain. Does anyone have suggestions on a suitable existing strain to use, or perhaps have flies that have been IPC ablated?